Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Artery Obstruction | 18 | 2020 | 39 | 4.130 |
Why?
|
| Kidney | 19 | 2020 | 1241 | 2.350 |
Why?
|
| Renal Circulation | 11 | 2018 | 61 | 2.200 |
Why?
|
| Hypertension, Renovascular | 6 | 2016 | 14 | 1.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2017 | 294 | 1.040 |
Why?
|
| Natural Language Processing | 1 | 2023 | 37 | 0.880 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2016 | 3362 | 0.850 |
Why?
|
| Adiposity | 4 | 2017 | 70 | 0.850 |
Why?
|
| Swine | 19 | 2017 | 555 | 0.840 |
Why?
|
| Radiation Oncology | 1 | 2023 | 119 | 0.780 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2014 | 53 | 0.680 |
Why?
|
| Atherosclerosis | 4 | 2016 | 244 | 0.670 |
Why?
|
| Renal Artery | 3 | 2018 | 64 | 0.670 |
Why?
|
| Fibrosis | 11 | 2020 | 203 | 0.610 |
Why?
|
| Oxygen Consumption | 4 | 2014 | 239 | 0.560 |
Why?
|
| Disease Models, Animal | 15 | 2018 | 2232 | 0.530 |
Why?
|
| Microcirculation | 6 | 2018 | 106 | 0.490 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2016 | 1204 | 0.490 |
Why?
|
| Angioplasty | 2 | 2014 | 70 | 0.480 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2013 | 6 | 0.480 |
Why?
|
| Glomerular Filtration Rate | 7 | 2016 | 384 | 0.480 |
Why?
|
| Endothelial Cells | 3 | 2014 | 428 | 0.460 |
Why?
|
| Kidney Diseases | 2 | 2014 | 418 | 0.450 |
Why?
|
| Metabolic Syndrome | 4 | 2018 | 141 | 0.440 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 663 | 0.440 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 159 | 0.430 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2016 | 318 | 0.430 |
Why?
|
| Kidney Tubules | 2 | 2012 | 94 | 0.430 |
Why?
|
| Kidney Medulla | 1 | 2012 | 80 | 0.410 |
Why?
|
| Microvessels | 5 | 2016 | 70 | 0.410 |
Why?
|
| Animals | 27 | 2020 | 26582 | 0.400 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 592 | 0.350 |
Why?
|
| Myocardium | 4 | 2016 | 529 | 0.340 |
Why?
|
| Cardiomyopathies | 3 | 2016 | 240 | 0.320 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 429 | 0.320 |
Why?
|
| Hypertension | 3 | 2015 | 1141 | 0.310 |
Why?
|
| Oxidative Stress | 10 | 2016 | 447 | 0.310 |
Why?
|
| Oxygen | 6 | 2014 | 726 | 0.290 |
Why?
|
| Obesity | 4 | 2015 | 963 | 0.290 |
Why?
|
| Mitochondria, Heart | 3 | 2016 | 50 | 0.290 |
Why?
|
| Macrophages | 3 | 2013 | 554 | 0.270 |
Why?
|
| Hemodynamics | 6 | 2015 | 711 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 878 | 0.260 |
Why?
|
| Patulin | 1 | 2024 | 1 | 0.240 |
Why?
|
| Malus | 1 | 2024 | 3 | 0.240 |
Why?
|
| Chitosan | 1 | 2024 | 18 | 0.240 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2013 | 59 | 0.220 |
Why?
|
| Water Pollutants, Chemical | 1 | 2024 | 135 | 0.220 |
Why?
|
| Inflammation | 5 | 2013 | 920 | 0.210 |
Why?
|
| Autophagy | 2 | 2014 | 149 | 0.200 |
Why?
|
| Acute Kidney Injury | 2 | 2014 | 295 | 0.180 |
Why?
|
| Female | 17 | 2017 | 44534 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 1673 | 0.170 |
Why?
|
| Collateral Circulation | 1 | 2018 | 35 | 0.170 |
Why?
|
| Renal Veins | 2 | 2014 | 28 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2018 | 407 | 0.150 |
Why?
|
| Time Factors | 4 | 2014 | 5210 | 0.150 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.140 |
Why?
|
| Cardiolipins | 1 | 2016 | 17 | 0.140 |
Why?
|
| Mice | 4 | 2020 | 11352 | 0.140 |
Why?
|
| Ultrasonic Therapy | 1 | 2016 | 32 | 0.140 |
Why?
|
| Sus scrofa | 4 | 2018 | 45 | 0.140 |
Why?
|
| Apoptosis | 4 | 2016 | 1683 | 0.130 |
Why?
|
| Furosemide | 2 | 2012 | 33 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2012 | 2601 | 0.130 |
Why?
|
| Endothelial Progenitor Cells | 1 | 2014 | 13 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 329 | 0.130 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 47 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 299 | 0.120 |
Why?
|
| Ischemia | 1 | 2016 | 243 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 92 | 0.120 |
Why?
|
| Hypertrophy | 1 | 2013 | 62 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 55 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2014 | 39 | 0.120 |
Why?
|
| Stents | 2 | 2013 | 377 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 136 | 0.120 |
Why?
|
| Arginase | 1 | 2013 | 16 | 0.120 |
Why?
|
| Kidney Cortex | 1 | 2013 | 33 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 32 | 0.120 |
Why?
|
| Arterial Pressure | 1 | 2013 | 38 | 0.120 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 15 | 0.120 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 50 | 0.120 |
Why?
|
| Atrophy | 1 | 2013 | 117 | 0.110 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 73 | 0.110 |
Why?
|
| Humans | 9 | 2023 | 86645 | 0.110 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2013 | 61 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 1078 | 0.110 |
Why?
|
| Valine | 1 | 2013 | 69 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2014 | 377 | 0.110 |
Why?
|
| Tetrazoles | 1 | 2013 | 50 | 0.110 |
Why?
|
| Nephritis | 1 | 2012 | 20 | 0.110 |
Why?
|
| Oximetry | 1 | 2013 | 84 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2013 | 80 | 0.110 |
Why?
|
| Blood Volume | 1 | 2012 | 51 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2012 | 95 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 1531 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 336 | 0.100 |
Why?
|
| Diuretics | 1 | 2012 | 124 | 0.100 |
Why?
|
| Proteinuria | 1 | 2012 | 107 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2012 | 105 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2013 | 458 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 1801 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 2705 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 275 | 0.100 |
Why?
|
| Heart Rate | 1 | 2013 | 492 | 0.100 |
Why?
|
| Capillaries | 1 | 2011 | 91 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 151 | 0.100 |
Why?
|
| Mitochondria | 1 | 2014 | 535 | 0.090 |
Why?
|
| Reperfusion | 1 | 2010 | 31 | 0.090 |
Why?
|
| Peptides | 1 | 2014 | 639 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 197 | 0.090 |
Why?
|
| Male | 7 | 2017 | 40967 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2014 | 534 | 0.090 |
Why?
|
| Kidney Function Tests | 3 | 2014 | 123 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 3 | 2014 | 133 | 0.080 |
Why?
|
| Aged | 4 | 2017 | 18415 | 0.070 |
Why?
|
| Prognosis | 1 | 2013 | 3680 | 0.070 |
Why?
|
| Random Allocation | 2 | 2016 | 332 | 0.070 |
Why?
|
| Contrast Media | 1 | 2010 | 1078 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1830 | 0.060 |
Why?
|
| Adult | 4 | 2017 | 25648 | 0.060 |
Why?
|
| Phytic Acid | 1 | 2024 | 3 | 0.060 |
Why?
|
| Blood Pressure | 3 | 2016 | 1143 | 0.060 |
Why?
|
| Oligopeptides | 2 | 2016 | 179 | 0.060 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2024 | 30 | 0.060 |
Why?
|
| Adsorption | 1 | 2024 | 54 | 0.060 |
Why?
|
| Middle Aged | 3 | 2017 | 25028 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1749 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2024 | 493 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 154 | 0.050 |
Why?
|
| Kinetics | 1 | 2024 | 1513 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 197 | 0.040 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2016 | 2 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2016 | 21 | 0.040 |
Why?
|
| Biomarkers | 2 | 2013 | 1718 | 0.040 |
Why?
|
| Mitochondrial Diseases | 1 | 2016 | 10 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1578 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 21 | 0.030 |
Why?
|
| Multidetector Computed Tomography | 1 | 2016 | 54 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 83 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 80 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 96 | 0.030 |
Why?
|
| Electron Transport | 1 | 2015 | 71 | 0.030 |
Why?
|
| Prenatal Injuries | 1 | 2014 | 6 | 0.030 |
Why?
|
| Iran | 1 | 2014 | 15 | 0.030 |
Why?
|
| Antioxidants | 1 | 2016 | 223 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 50 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 114 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2014 | 30 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 235 | 0.030 |
Why?
|
| Cholesterol | 1 | 2016 | 356 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 94 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 262 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 95 | 0.030 |
Why?
|
| Valsartan | 1 | 2013 | 20 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2014 | 130 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 674 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 639 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 46 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 164 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2012 | 176 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 912 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 2012 | 15 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 213 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 269 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2014 | 271 | 0.030 |
Why?
|
| Heart | 1 | 2014 | 539 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2013 | 782 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2013 | 240 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 232 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1239 | 0.020 |
Why?
|
| Hypoxia | 1 | 2016 | 641 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1753 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1805 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2818 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 776 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1991 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3092 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 443 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4213 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2894 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2378 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 1851 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5417 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6509 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7993 | 0.010 |
Why?
|